US Stock MarketDetailed Quotes

XTLB XTL Biopharmaceuticals

Watchlist

1.850
-0.030-1.60%

Close Nov 26 16:00 ET

10.08MMarket Cap-59677P/E (TTM)

XTL Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-30.28%175K

-13.07%765K

-11.11%200K

-25.98%151K

-19.31%163K

0.80%251K

-14.65%880K

-21.33%225K

-2.86%204K

-33.33%202K

Selling and administrative expenses

-28.99%169K

-13.65%734K

-11.42%194K

-27.86%145K

-16.04%157K

-2.06%238K

-15.08%850K

-21.79%219K

-1.47%201K

-37.04%187K

-General and administrative expense

-28.99%169K

-13.65%734K

-11.42%194K

-27.86%145K

-16.04%157K

-2.06%238K

-15.08%850K

-21.79%219K

-1.47%201K

-37.04%187K

Research and development costs

-53.85%6K

3.33%31K

0.00%6K

100.00%6K

-60.00%6K

116.67%13K

0.00%30K

0.00%6K

-50.00%3K

150.00%15K

Operating profit

30.28%-175K

13.07%-765K

11.11%-200K

25.98%-151K

19.31%-163K

-0.80%-251K

14.65%-880K

21.33%-225K

2.86%-204K

33.33%-202K

Net non-operating interest income expense

53.85%-6K

48.00%37K

240.74%92K

-290.00%-19K

-283.33%-23K

-116.67%-13K

292.31%25K

775.00%27K

10K

-100.00%-6K

Non-operating interest income

-16.67%10K

13.89%41K

-31.25%11K

-25.00%9K

80.00%9K

300.00%12K

350.00%36K

--16K

--12K

66.67%5K

Non-operating interest expense

-36.00%16K

----

1,300.00%28K

190.91%32K

177.78%25K

----

--2K

83.33%11K

Total other finance cost

----

-63.64%4K

----

-47.62%11K

----

Other net income (expense)

201.68%666K

-113.79%-1.05M

68.00%-176K

92.82%-45K

-131.17%-178K

-186.07%-655K

-133.33%-493K

-123.06%-550K

-7.18%-627K

90.88%-77K

Gain on sale of security

201.68%666K

-113.79%-1.05M

68.00%-176K

92.82%-45K

-131.17%-178K

-186.07%-655K

-133.33%-493K

-123.06%-550K

-7.18%-627K

90.88%-77K

Income before tax

152.77%485K

-32.20%-1.78M

62.03%-284K

73.81%-215K

-27.72%-364K

-281.62%-919K

-409.89%-1.35M

-135.70%-748K

-3.27%-821K

75.22%-285K

Income tax

Net income

152.77%485K

-32.20%-1.78M

62.03%-284K

73.81%-215K

-27.72%-364K

-281.62%-919K

-409.89%-1.35M

-135.70%-748K

-3.27%-821K

75.22%-285K

Net income continuous Operations

152.77%485K

-32.20%-1.78M

62.03%-284K

73.81%-215K

-27.72%-364K

-281.62%-919K

-409.89%-1.35M

-135.70%-748K

-3.27%-821K

75.22%-285K

Minority interest income

Net income attributable to the parent company

152.77%485K

-32.20%-1.78M

62.03%-284K

73.81%-215K

-27.72%-364K

-281.62%-919K

-409.89%-1.35M

-135.70%-748K

-3.27%-821K

75.22%-285K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

152.77%485K

-32.20%-1.78M

62.03%-284K

73.81%-215K

-27.72%-364K

-281.62%-919K

-409.89%-1.35M

-135.70%-748K

-3.27%-821K

75.22%-285K

Basic earnings per share

159.29%0.1

-50.00%-0.3

54.08%-0.0645

33.20%-0.0668

-268.65%-0.1687

-300.00%-0.2

-125.00%-0.1

-40.56%-0.1406

50.00%-0.1

Diluted earnings per share

159.29%0.1

-50.00%-0.3

54.08%-0.0645

33.20%-0.0668

-281.62%-0.1687

-447.15%-0.2

-137.96%-0.1

-40.56%-0.1406

50.00%-0.1

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-30.28%175K	-13.07%765K	-11.11%200K	-25.98%151K	-19.31%163K	0.80%251K	-14.65%880K	-21.33%225K	-2.86%204K	-33.33%202K
Selling and administrative expenses	-28.99%169K	-13.65%734K	-11.42%194K	-27.86%145K	-16.04%157K	-2.06%238K	-15.08%850K	-21.79%219K	-1.47%201K	-37.04%187K
-General and administrative expense	-28.99%169K	-13.65%734K	-11.42%194K	-27.86%145K	-16.04%157K	-2.06%238K	-15.08%850K	-21.79%219K	-1.47%201K	-37.04%187K
Research and development costs	-53.85%6K	3.33%31K	0.00%6K	100.00%6K	-60.00%6K	116.67%13K	0.00%30K	0.00%6K	-50.00%3K	150.00%15K
Operating profit	30.28%-175K	13.07%-765K	11.11%-200K	25.98%-151K	19.31%-163K	-0.80%-251K	14.65%-880K	21.33%-225K	2.86%-204K	33.33%-202K
Net non-operating interest income expense	53.85%-6K	48.00%37K	240.74%92K	-290.00%-19K	-283.33%-23K	-116.67%-13K	292.31%25K	775.00%27K	10K	-100.00%-6K
Non-operating interest income	-16.67%10K	13.89%41K	-31.25%11K	-25.00%9K	80.00%9K	300.00%12K	350.00%36K	--16K	--12K	66.67%5K
Non-operating interest expense	-36.00%16K	----	----	1,300.00%28K	190.91%32K	177.78%25K	----	----	--2K	83.33%11K
Total other finance cost	----	-63.64%4K	----	----	----	----	-47.62%11K	----	----	----
Other net income (expense)	201.68%666K	-113.79%-1.05M	68.00%-176K	92.82%-45K	-131.17%-178K	-186.07%-655K	-133.33%-493K	-123.06%-550K	-7.18%-627K	90.88%-77K
Gain on sale of security	201.68%666K	-113.79%-1.05M	68.00%-176K	92.82%-45K	-131.17%-178K	-186.07%-655K	-133.33%-493K	-123.06%-550K	-7.18%-627K	90.88%-77K
Income before tax	152.77%485K	-32.20%-1.78M	62.03%-284K	73.81%-215K	-27.72%-364K	-281.62%-919K	-409.89%-1.35M	-135.70%-748K	-3.27%-821K	75.22%-285K
Income tax
Net income	152.77%485K	-32.20%-1.78M	62.03%-284K	73.81%-215K	-27.72%-364K	-281.62%-919K	-409.89%-1.35M	-135.70%-748K	-3.27%-821K	75.22%-285K
Net income continuous Operations	152.77%485K	-32.20%-1.78M	62.03%-284K	73.81%-215K	-27.72%-364K	-281.62%-919K	-409.89%-1.35M	-135.70%-748K	-3.27%-821K	75.22%-285K
Minority interest income
Net income attributable to the parent company	152.77%485K	-32.20%-1.78M	62.03%-284K	73.81%-215K	-27.72%-364K	-281.62%-919K	-409.89%-1.35M	-135.70%-748K	-3.27%-821K	75.22%-285K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	152.77%485K	-32.20%-1.78M	62.03%-284K	73.81%-215K	-27.72%-364K	-281.62%-919K	-409.89%-1.35M	-135.70%-748K	-3.27%-821K	75.22%-285K
Basic earnings per share	159.29%0.1	-50.00%-0.3	0	54.08%-0.0645	33.20%-0.0668	-268.65%-0.1687	-300.00%-0.2	-125.00%-0.1	-40.56%-0.1406	50.00%-0.1
Diluted earnings per share	159.29%0.1	-50.00%-0.3	0	54.08%-0.0645	33.20%-0.0668	-281.62%-0.1687	-447.15%-0.2	-137.96%-0.1	-40.56%-0.1406	50.00%-0.1
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data